The Right Treatment for the Right Patient: Personalizing COPD Therapy
Managing COPD effectively means matching the right treatment to the right patient. PA Bizik explains how GOLD 2025 classifies patients into treatment groups and highlights how to adjust therapy based on patient response and disease progression. He emphasizes inhaled therapies (LABA, LAMA, ICS), the role of adherence and inhaler technique, and when escalation to advanced options like PDE4 inhibitors or biologics may be warranted. Personalization is the cornerstone of successful COPD care.
Key Takeaways:
- Evaluate a patient’s functional status at each visit.
- Evaluate a patient’s functional status by asking questions including the mMRC.
- Utilize the GOLD guidelines for appropriate treatments.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Mangement, and Prevention of Chronic Obstructive Pulmonary Disease.; 2025. https://goldcopd.org/2025-gold-report/
Supported by
